Golden Dome isn’t just about intercepting enemy weapons. It’s also about modernizing the civilian systems that millions of Americans rely on every day to fly safely.
DoD should find pragmatic ways to address the problems it can solve right now. This will require a willingness to embrace more agile and innovative solutions.
Elevating AI and chips to national priorities is essential, but it’s also time to give biotechnology and biosecurity the same strategic focus. The U.S. should stop treating biosecurity as a low-visibility, high-impact endeavor and recommit to biotechnology as a launchpad for economic prosperity, with biosecurity as the guardrails that keep us accelerating in the right direction into the future.
The future of United States industrial growth, a key component of national security, rests in the establishment of biotechnology as a new pillar of industrial domestic manufacturing. Fortunately the opportunity exists to develop the science, infrastructure and workforce to do this.
In biodefense, there is no more powerful a statement than the first words of the new National Biodefense Strategy: “It is a vital interest of the United States to manage the risk of biological incidents, whether naturally occurring, accidental or deliberate.”
